BREAST CANCER RES TR 润色咨询

BREAST CANCER RESEARCH AND TREATMENT

出版年份:1981 年文章数:6642 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:5.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=d76d1212, cover=https://img.medsci.cn/images/journal/cover/2021/zXi_202109271314348240.jpg, fullname=BREAST CANCER RESEARCH AND TREATMENT, abbr=BREAST CANCER RES TR, pyear=1981, frequence=Semimonthly, articleNumbers=6642, citedSelf2015=5.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.26月, reviewFee=null, pageFee=27020.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0167-6806, greenSci=https://www.greensci.net/search?kw=0167-6806, scijournal=https://www.scijournal.org/impact-factor-of-BREAST-CANCER-RES-TR.shtml, medsciHotlightString=null, medsciHotlightRealtime=9.41, medsciHotlight=12.984, medsciHotlight5year=17.4611, citescore=6.8, hIndex=154, impactFactor=3.8, orgnization=Springer New York, orgnizationUrl=http://springerlink.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区, smallclassCas=医学 2 区, website=https://www.springer.com/journal/10549?utm_source=medsci&utm_medium=display&utm_content=text_link&utm_campaign=BSCN_4_YD01_CN_organic_MedSci_2020_homepage, websiteHits=19627, guideForAuthor=https://www.springer.com/journal/10549/submission?utm_source=medsci&utm_medium=display&utm_content=text_link&utm_campaign=BSCN_3_YD01_CN_organic_MedSci_2020_publish, guideForAuthorHits=1186, submitWebsite=https://www.editorialmanager.com/brea/default.aspx, submitWebsiteHits=7466, content=Breast Cancer Research and Treatment provides the surgeon radiotherapist medical oncologist endocrinologist epidemiologist immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a 'market place' for breast cancer topics which cuts across all the usual lines of disciplines providing a site for presenting pertinent investigations and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer. Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries and is truly a multidisiplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these journals provides a focus on the unique problems of breast cancer. There has been no convenient arena for the discussion and resolution of ongoing controversies in breast cancer treatment or for the consideration of thoughtful speculation and comments on current work. Breast Cancer Research and Treatment aims to fill this need. Each issue contains several articles dealing with original laboratory investigations and articles dealing with clinical studies. There are sections devoted to invited review articles pro and con discussions of controversial subjects book reviews meeting reports and editorials. Panel discussions are presented which bring together experts to consider important topics. There is a section for letters to the editor which provides for a lively exchange of opinions on previously published articles or other topics of interest. There is also an opportunity to publish the proceedings of special workshops symposia etc. devoted to breast cancer. All manuscripts are peer reviewed by a distinguished group of advisory editors from many countries covering all of the various disciplines of breast cancer., totalCites=25242, brief=BREAST CANCER RES TR杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的优秀级杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=BREAST CANCER RES TR杂志级别还可以,但是相对来说,比较冷门,关注人数偏少,有些可能是国内不太熟悉,但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿,稿源可能未必丰富,发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=d76d1212'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=23), ImpactFactorTagDto(id=1422, tagName=SNP, createdHits=3), ImpactFactorTagDto(id=43315, tagName=breast cancer, createdHits=3), ImpactFactorTagDto(id=285, tagName=乳腺癌, createdHits=2), ImpactFactorTagDto(id=23938, tagName=肿瘤遗传, createdHits=1), ImpactFactorTagDto(id=1415, tagName=miRNA, createdHits=1), ImpactFactorTagDto(id=123, tagName=Pathology, createdHits=1), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=1), ImpactFactorTagDto(id=45057, tagName=乳腺癌基础, createdHits=1), ImpactFactorTagDto(id=45056, tagName=乳腺癌临床, createdHits=1), ImpactFactorTagDto(id=23304, tagName=分子标记物, createdHits=1), ImpactFactorTagDto(id=43573, tagName=乳腺癌乳房再造, createdHits=1), ImpactFactorTagDto(id=2964, tagName=分子生物学, createdHits=1), ImpactFactorTagDto(id=919, tagName=meta-analysis, createdHits=1), ImpactFactorTagDto(id=66058, tagName=polymorphism, createdHits=1), ImpactFactorTagDto(id=65679, tagName=临床病例分析, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=3.88), GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.73), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.45), GetImpactFactorCiteScoreListResponse(year=2019, citescore=6.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.8)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=17.609), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=14.405), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=13.028), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=10.537), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=9.41)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=82/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=74/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY - SCIE, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0167-6806[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=BREAST CANCER RESEARCH AND TREATMENT[ta], article_number=368, article_number_cn=38, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
BREAST CANCER RES TR/BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
影响指数话题
预警等级
MedSci期刊指数
9.41 (MedSci实时期刊指数) | 17.4611 (5年期刊指数)
CiteScore值
6.8
h-index
154
h5-median
暂无数据
出版社/管理机构
杂志由 Springer New York 出版或管理
出版国家/地区
Netherlands 荷兰
出版周期
Semimonthly
出版年份
1981
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
ONCOLOGY - SCIE Q2
中科院分区
大类:医学 2区
小类:医学 2 区